Biologic Drug Product CDMO Benchmarking (4th Ed.)

Report Overview

ISR’s Biologic Drug Product Contract Manufacturing Quality Benchmarking (4th Edition) report brings with it a wealth of knowledge and information created with two goals in mind, help biopharmaceutical companies make more informed CMO decisions, and help CMOs optimize operational and marketing strategies.

This report provides pharmaceutical companies and contract manufacturers a comprehensive analysis of current outsourcing trends and practices, in addition to a quantitative analysis of CMO service quality across a series of 23 performance attributes specific to outsourced drug product manufacturing. In this Consumer Reports-style analysis, ISR presents data on 382 service encounters from 110 respondents who have been involved in outsourced drug product projects in the past 18 months.

What you will learn:

Drug developers:

• Make a more educated purchase of CMO services by understanding which manufacturers best fit your company’s needs in addition to how individual CMOs have measured up to sponsor-peer expectations on similar projects
• Uncover which CMO attributes drive outsourcing partner selection for outsourced biologic drug product manufacturing as well as which CMO attributes have gained importance over the past 12 months among industry peers
• Gain insight into CMO customer loyalty, an index based on customer satisfaction, willingness to recommend, and likelihood to use again, along with verbatim responses from outsourcers regarding their experiences with specific CMOs

Contract Manufacturers:

• Understand your company’s competitive positioning as well as delivery strengths and weaknesses and use this information to develop targeted messaging on true areas of strength
• Compare your company’s performance against its competitors across 23 performance metrics specific to outsourced drug product manufacturing and related services
• Gain insight into drug developers’ outsourcing preferences and practices with respect to CMO selection and CMO preference for outsourced biologic drug product manufacturing

Major Topics:

• Outsourcing Philosophies and Practices
• CMO Selection Drivers
• CMO Perceptions and Interactions
• CMO Performance and Loyalty
• Biologic Drug Product CMO Competitive Landscape
• Company Service Quality Profiles
• Study Data